Teodor A.
- Country
- Bulgaria
- Department
- Clinic of Skin and Venereal diseases
Research Overview
- A Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Galvokimig in Adults with Moderate to Severe Atopic Dermatitis
- Evaluation of Upadacitinib Efficacy and Safety in Adult and Adolescent Patients with Severe Alopecia Areata: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 6 of 105 partner sites.
Specializations
Dermatological Research
The investigator specializes in studying and treating severe alopecia areata, focusing on advanced therapeutic approaches for this autoimmune hair loss condition.
- Autoimmune Hair Loss Management
- Long-term Treatment Outcomes
- Therapeutic Response Assessment
Their research encompasses both adult and adolescent patient populations, evaluating novel treatment approaches for severe cases.
Immunological Studies
The investigator's work centers on immunomodulatory therapeutics in dermatological conditions, particularly examining innovative treatment options for autoimmune-mediated hair loss disorders.
- Immune System Regulation
- Treatment Response Patterns
- Therapeutic Dose Optimization
Their research explores various dosing strategies and treatment durations to optimize therapeutic outcomes.
Clinical Assessment
The investigator utilizes specialized evaluation tools including the Severity of Alopecia Tool (SALT) to measure and track treatment effectiveness in patients with severe hair loss conditions.
- Disease Severity Assessment
- Treatment Response Monitoring
- Clinical Outcome Measures
Their work includes comprehensive evaluation of treatment efficacy across different patient demographics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.